Scientists test Three-Pronged attack on aggressive sarcoma
NCT ID NCT05813327
Summary
This early-stage trial is testing a new three-part treatment for people with intermediate or high-grade soft tissue sarcoma in the arms, legs, or trunk. Before surgery, participants receive a new drug called ADI-PEG 20 along with a standard chemotherapy (ifosfamide) and radiation therapy. The main goals are to find the safest dose of this combination and to see how well it shrinks the tumor to make surgery more successful.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOFT TISSUE SARCOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Washington University School of Medicine
St Louis, Missouri, 63110, United States
Conditions
Explore the condition pages connected to this study.